I 
115TH CONGRESS 
2D SESSION 
H. R. 5581 
To require training for prescribers of controlled substances, and for other 
purposes. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 23, 2018 
Mrs. BROOKS of Indiana (for herself and Mr. SCHNEIDER) introduced the fol-
lowing bill; which was referred to the Committee on Energy and Com-
merce, and in addition to the Committee on the Judiciary, for a period 
to be subsequently determined by the Speaker, in each case for consider-
ation of such provisions as fall within the jurisdiction of the committee 
concerned 
A BILL 
To require training for prescribers of controlled substances, 
and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Abuse Deterrent and 
Prescriber Training Act of 2018’’ or the ‘‘ADAPT Act of 
2018’’. 
VerDate Sep 11 2014 
22:45 Apr 25, 2018
Jkt 079200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H5581.IH
H5581
daltland on DSKBBV9HB2PROD with BILLS
SEC. 2. PRACTITIONER EDUCATION. 
(a) IN GENERAL.—Part C of the Controlled Sub-
stances Act (21 U.S.C. 821 et seq.) is amended— 
(1) in section 303 (21 U.S.C. 823), by adding 
at the end the following: 
‘‘(k)(1) The Attorney General shall not register, or 
renew the registration of, a practitioner under subsection 
(f) who is licensed under State law to prescribe controlled 
substances in schedule II, III, IV, or V, unless the practi-
tioner submits to the Attorney General, for each such reg-
istration or renewal request, a written certification that 
the practitioner has completed 3 hours of training under 
a training program meeting the criteria in paragraph (2) 
during the period applicable under paragraph (5). 
‘‘(2) A training program meets the criteria in this 
paragraph if the program— 
‘‘(A) includes information on— 
‘‘(i) safe opioid prescribing guidelines, in-
cluding the Guideline for Prescribing Opioids 
for Chronic Pain issued by the Centers for Dis-
ease Control and Prevention; 
‘‘(ii) the risks of opioid medications and 
other prescription drugs that are controlled sub-
stances; 
‘‘(iii) pain management, including the need 
to provide individualized care particularly for 
VerDate Sep 11 2014 
22:45 Apr 25, 2018
Jkt 079200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H5581.IH
H5581
daltland on DSKBBV9HB2PROD with BILLS
active cancer treatment, palliative care, and 
end-of-life care; 
‘‘(iv) early detection of opioid and other 
substance use disorders; 
‘‘(v) the risks of prescribing opioids to any 
individual in recovery from a substance use dis-
order; 
‘‘(vi) a basic understanding of addiction; 
‘‘(vii) the treatment of opioid-dependent 
patients and their treatment options; 
‘‘(viii) the risks of misuse of all prescrip-
tion drugs that are controlled substances; and 
‘‘(ix) alternative non-opioid pain manage-
ment medications and other effective treat-
ments; and 
‘‘(B) is— 
‘‘(i) approved by the State agency with pri-
mary responsibility for licensing the practitioner 
to prescribe controlled substances; or 
‘‘(ii) if such State agency does not have in 
effect an approval of any training program for 
purposes of this subsection, conforms to the 
model training program in effect under para-
graph (4). 
VerDate Sep 11 2014 
22:45 Apr 25, 2018
Jkt 079200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H5581.IH
H5581
daltland on DSKBBV9HB2PROD with BILLS
‘‘(3) Notwithstanding paragraph (2), a training pro-
gram on prescribing opioids used by a State for purposes 
of licensing health care practitioners is deemed to meet 
the criteria in paragraph (2) if the program has been in 
effect since before the date of enactment of the Abuse De-
terrent and Prescriber Training Act of 2018. 
‘‘(4) The Secretary of Health and Human Services 
shall— 
‘‘(A) by not later than 60 days after the date 
of enactment of the Abuse Deterrent and Prescriber 
Training Act of 2018, develop a model training pro-
gram on prescribing opioids to be used for purposes 
of paragraph (2)(B)(ii); and 
‘‘(B) by not later than 90 days after such date 
of enactment, provide information about such model 
training program to the Attorney General, pre-
scribers, State licensing boards, and continuing med-
ical education providers. 
‘‘(5)(A) In the case of a registration request, and in 
the case of the first renewal request of a practitioner after 
the date of enactment of the Abuse Deterrent and Pre-
scriber Training Act of 2018, the training required by 
paragraph (1) shall occur during the 1-year period pre-
ceding the registration or first renewal request. 
VerDate Sep 11 2014 
22:45 Apr 25, 2018
Jkt 079200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H5581.IH
H5581
daltland on DSKBBV9HB2PROD with BILLS